Hanuman Medical Foundation

There is still no cure for type 1 diabetes, despite decades of research and promises. Most people with the disease say that a "cure" should mean being able to live a healthy life, free of dependence on external insulin—and without using powerful drugs that suppress the body's immune response. Only one current line of research holds real hope for both in the near term: the therapy known as encapsulated islets or the bioartificial pancreas. Hanuman Medical Foundation supports this vital research through its work with the Islet Sheet Project, a long-term collaboration by a team of leading diabetes researchers and medical inventors.

The Islet Sheet Project expects to begin clinical trials in 2013. This can be life-changing news for people with type 1 diabetes and their loved ones. We're committed to real progress, not promises. Please read on … and join us.

"We believe this technology has significant potential to be considered a 'cure' for type 1 diabetes."

—The authors of Targeting a Cure for Type 1 Diabetes

NEWS

Large-Animal Trials of Islet Sheet Begin

January 17, 2012

Today the definitive large-animal study of the Islet Sheet encapsulation device kicked off with the first surgical procedure under the approved protocol. This was a practice pancreatectomy on a... READ MORE

Scott King Talks to JDCA About the Islet Sheet

December 20, 2011

The Juvenile Diabetes Cure Alliance (JDCA) blog has published an interview with Scott R. King, president of Islet Sheet Medical and co-inventor of the Islet Sheet therapy for type 1 diabetes. JDCA... READ MORE

ASK AN EXPERT

Have a question about diabetes research, especially about islet transplantation? Looking for sound advice about managing type 1 diabetes? Interested in the work of our foundation? Ask here, and an expert from the Hanuman team will respond.

Q.

There already are several large foundations that focus on a cure for type 1 diabetes—for example, JDRF and DRI. Why create another nonprofit foundation that can only siphon off some of the scarce contributions for very expensive research?

A.

That’s a key question, Michael. Hanuman Medical Foundation was created to fund essential research to test a particular modality of therapy for type 1 diabetes: the use of an alginate sheet to encapsulate living islet cells, implanted in patients with... READ MORE

Scott King

This blog is most often authored by Scott R. King, president and founder of Islet Sheet Medical, a biotechnology company working with Hanuman Medical Foundation. Scott was diagnosed with type 1 diabetes in 1977, and since then has been devoted to understanding and ameliorating the disease. The Sheet shares updates on our work and welcomes comments.

The Crucial Year for Islet Sheet is 2012

January 17th, 2012

A year ago I posted an article to this blog titled “The Crucial Year for Islet Sheet is 2011.”  I was off by a year, as it turned out; last year was a transition year. The crucial year begins today. As I wrote last year, “The definitive experimental model is large animals (pig, dog, monkey)... READ MORE

Advice for Paul of Michigan

January 2nd, 2012

Question: Hi Scott – my name is Paul B***** from Oxford, Michigan. I am a type 1 diabetic, diagnosed at age six. I am now studying Cell and Molecular Biology as an undergrad at Grand Valley State University. I was reading your work, and I’ve become fascinated with the idea of bioengineering and immunology. It’s... READ MORE

Animated views of how the Islet Sheet with its encapsulated islets works